Browse > Article
http://dx.doi.org/10.4062/biomolther.2014.039

Dependence Potential of the Synthetic Cannabinoids JWH-073, JWH-081, and JWH-210: In Vivo and In Vitro Approaches  

Cha, Hye Jin (Pharmacological Research Division, Toxicological Evaluation and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety)
Lee, Kwang-Wook (Pharmacological Research Division, Toxicological Evaluation and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety)
Song, Min-Ji (Pharmacological Research Division, Toxicological Evaluation and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety)
Hyeon, Yang-Jin (Pharmacological Research Division, Toxicological Evaluation and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety)
Hwang, Ji-Young (School of Pharmacy, Sungkyunkwan University)
Jang, Choon-Gon (School of Pharmacy, Sungkyunkwan University)
Ahn, Joon-Ik (Pharmacological Research Division, Toxicological Evaluation and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety)
Jeon, Seol-Hee (Pharmacological Research Division, Toxicological Evaluation and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety)
Kim, Hyun-Uk (Pharmacological Research Division, Toxicological Evaluation and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety)
Kim, Young-Hoon (Pharmacological Research Division, Toxicological Evaluation and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety)
Seong, Won-Keun (Pharmacological Research Division, Toxicological Evaluation and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety)
Kang, Hoil (Pharmacological Research Division, Toxicological Evaluation and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety)
Yoo, Han Sang (Department of Infectious Diseases, College of Veterinary Medicine, Seoul National University)
Jeong, Ho-Sang (Pharmacological Research Division, Toxicological Evaluation and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety)
Publication Information
Biomolecules & Therapeutics / v.22, no.4, 2014 , pp. 363-369 More about this Journal
Abstract
Synthetic cannabinoids (CBs) such as the JWH series have caused social problems concerning their abuse liability. Because the JWH series produces euphoric and hallucinogenic effects, they have been distributed illegally under street names such as "Spice" and "Smoke". Many countries including Korea have started to schedule some of the JWH series compounds as controlled substances, but there are a number of JWH series chemicals that remain uncontrolled by law. In this study, three synthetic CBs with different binding affinities to the $CB_1$ receptor (JWH-073, 081, and 210) and ${\Delta}^9$-tetrahydrocannabinol (${\Delta}^9$-THC) were evaluated for their potential for psychological dependence. The conditioned place preference test (unbiased method) and self-administration test (fixed ratio of 1) using rodents were conducted. $K_i$ values of the three synthetic cannabinoids were calculated as supplementary data using a receptor binding assay and overexpressed $CB_1$ protein membranes to compare dependence potential with $CB_1$ receptor binding affinity. All mice administered JWH-073, 081, or 210 showed significantly increased time spent at unpreferred space in a dose-dependence manner in the conditioned place preference test. In contrast, all tested substances except ${\Delta}^9$-THC showed aversion phenomenon at high doses in the conditioned place preference test. The order of affinity to the $CB_1$ receptor in the receptor binding assay was JWH-210 > JWH-081 >> JWH-073, which was in agreement with the results from the conditioned place preference test. However, no change in self-administration was observed. These findings suggest the possibility to predict dependence potential of synthetic CBs through a receptor binding assay at the screening level.
Keywords
Synthetic cannabinoid; ${\Delta}^9$-Tetrahydrocannabinol (${\Delta}^9$-THC); Psychological dependence; $CB_1$ receptor; Binding affinity;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Alexander, S. P., Mathie, A. and Peters, J. A. (2008) Guide to receptors and channels (GRAC). Br. J. Pharmacol. 153, S1-209.   DOI   ScienceOn
2 Atwood, B. K., Lee, D., Straiker, A., Widlanski, T. S. and Mackie, K. (2011) CP47, 497-C8 and JWH073, commonly found in 'Spice' herbal blends, are potent and efficacious CB1 cannabinoid receptor agonists. Eur. J. Pharmacol. 659, 139-145.   DOI
3 Aung, M. M., Griffi n, G., Huffman, J. W., Wu, M. J., Keel, C., Yang, B., Showalter, V. M., Abood, M. E. and Martin, B. R. (2000) Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB1 and CB2 receptor binding. Drug Alcohol Depend. 60, 133-140.   DOI
4 Showalter, V. M., Compton, D. R., Martin, B. R. and Abood, M. E. (1996) Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identifi cation of cannabinoid receptor subtype selective ligands. J. Pharmacol. Exp. Ther. 278, 989-999.
5 Uchiyama, N., Kikura-Hanajiri, R., Kawahara, N. and Goda, Y. (2009a) Identifi cation of a cannabimimetic indole as a designer drug in a herbal product. Forensic Toxicol. 27, 61-66.   DOI
6 Uchiyama, N., Kikura-Hanajiri, R., Kawahara, N., Haishima, Y. and Goda, Y. (2009b) Identifi cation of a cannabinoid analog as a new type of designer drug in a herbal product. Chem. Pharm. Bull. 57, 439-441.   DOI
7 Valjent, E. and Maldonado, R. (2000) A behavioural model to reveal place preference to delta9-tetrahydrocannabinol in mice. Psychopharmacology 147, 436-438.   DOI
8 Wu, D. F., Yang, L. Q., Goschke, A., Stumm, R., Brandenburg, L. S., Liang, Y. J., Hollt, V. and Koch, T. (2008) Role of receptor internalization in the agonist-induced desensitization of cannabinoid type 1 receptors. J. Neurochem. 104, 1132-1143.   DOI
9 Zangen, A., Solinas, M., Ikemoto, S., Goldberg, S. R. and Wise, R. A. (2006) Two brain sites for cannabinoid reward. J. Neurosci. 26, 4901-4907.   DOI
10 Roche, J. P., Bounds, S., Brown, S. and Mackie, K. (1999) A mutation in the second transmembrane region of the CB1 receptor selectively disrupts G protein signaling and prevents receptor internalization. Mol. Pharmacol. 56, 611-618.   DOI
11 Auwarter, V., Dresen, S., Weinmann, W., Muller, M., Puts, M. and Ferreiros, N. (2009) 'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs? J. Mass Spectrom. 44, 832-837.   DOI
12 Corcoran, M. E. and Amit, Z. (1974) Reluctance of rats to drink hashish suspensions: free-choice and forced consumption, and the effects of hypothalamic stimulation. Psychopharmacologia 35, 129-147.   DOI
13 Bozarth, M. A. (1987) Conditioned place preference: A parametric analysis using systemic heroin injections. In: Methods of assessing the reinforcing properties of abused drugs. (M. A. Bozarth, Ed), pp 241-273. Springer-Verlag, New York.
14 Carlezon, W. A. and Chartoff, E. H. (2007) Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation. Nat. Protoc. 2, 2987-2995.   DOI   ScienceOn
15 Chaperon, F. and Thiebot, M. H. (1999) Behavioral effects of cannabinoid agents in animals. Crit. Rev. Neurobiol. 13, 243-281.   DOI
16 Devane, W. A., Dysarz, F. A. 3rd, Johnson, M. R., Melvin, L. S. and Howlett, A. C. (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 34, 605-613.
17 Gaoni, Y. and Mechoulam, R. (1964) Isolation, structure, and partial synthesis of an active constituent of hashish. J. Am. Chem. Soc. 86, 1646-1647.   DOI
18 ElSohly, M. A., Gul, W., Wanas, A. S. and Radwan, M. M. (2014) Synthetic Cannabinoids: Analysis and Metabolites. Life Sci. 97, 78-90.   DOI
19 Hsieh, C., Brown, S., Derleth, C. and Mackie, K. (1999) Internalization and recycling of the CB1 cannabinoid receptor. J. Neurochem. 73, 493-501.
20 Leite, J. R. and Carlini, E. A. (1974) Failure to obtain 'cannabis-directed behavior' and abstinence syndrome in rats chronically treated with Cannabis sativa extracts. Psychopharmacologia 36, 133-145.   DOI
21 Jin, W., Brown, S., Roche, J. P., Hsieh, C., Celver, J. P., Kovoor, A., Chavkin, C. and Mackie, K. (1999) Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization. J. Neurosci. 19, 3773-3780.
22 Mackie, K. (2005) Distribution of cannabinoid receptors in the central and peripheral nervous system. Handb. Exp. Pharmacol. 168, 299-325.   DOI
23 Mucha, R. F., Van Der Kooy, D., O'Shaughnessy, M. and Bucenieks, P. (1982) Drug reinforcement studied by the use of place conditioning in rat. Brain Res. 243, 91-105.   DOI   ScienceOn
24 Narita, M., Akai, H., Nagumo, Y., Sunagawa, N., Hasebe, K., Nagase, H., Kita, T., Hara, C. and Suzuki, T. (2004) Implications of protein kinase C in the nucleus accumbens in the development of sensitization to methamphetamine in rats. Neuroscience 127, 941-948.   DOI   ScienceOn
25 Van Sickle, M. D., Duncan, M., Kingsley, P. J., Mouihate, A., Urbani, P., Mackie, K., Stella, N., Makriyannis, A., Piomelli, D. and Davison, J. S. (2005) Identifi cation and functional characterization of brainstem cannabinoid CB2 receptors. Science 310, 329-332.   DOI